Current and historical daily PE Ratio for Saniona AB (
OSTO:SANION
) from 2014 to Sep 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Saniona AB stock (OSTO:SANION) PE ratio as of Sep 22 2024 is 0.
More Details
Saniona AB (OSTO:SANION) PE Ratio (TTM) Chart
Saniona AB (OSTO:SANION) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1295
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Saniona AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-09-22 | At Loss | 2024-07-22 | At Loss |
| 2024-09-20 | At Loss | 2024-07-19 | At Loss |
| 2024-09-19 | At Loss | 2024-07-18 | At Loss |
| 2024-09-18 | At Loss | 2024-07-17 | At Loss |
| 2024-09-17 | At Loss | 2024-07-16 | At Loss |
| 2024-09-16 | At Loss | 2024-07-15 | At Loss |
| 2024-09-13 | At Loss | 2024-07-12 | At Loss |
| 2024-09-12 | At Loss | 2024-07-11 | At Loss |
| 2024-09-11 | At Loss | 2024-07-10 | At Loss |
| 2024-09-10 | At Loss | 2024-07-09 | At Loss |
| 2024-09-09 | At Loss | 2024-07-08 | At Loss |
| 2024-09-06 | At Loss | 2024-07-05 | At Loss |
| 2024-09-05 | At Loss | 2024-07-04 | At Loss |
| 2024-09-04 | At Loss | 2024-07-03 | At Loss |
| 2024-09-03 | At Loss | 2024-07-02 | At Loss |
| 2024-09-02 | At Loss | 2024-07-01 | At Loss |
| 2024-08-30 | At Loss | 2024-06-28 | At Loss |
| 2024-08-29 | At Loss | 2024-06-27 | At Loss |
| 2024-08-28 | At Loss | 2024-06-26 | At Loss |
| 2024-08-27 | At Loss | 2024-06-25 | At Loss |
| 2024-08-26 | At Loss | 2024-06-24 | At Loss |
| 2024-08-23 | At Loss | 2024-06-20 | At Loss |
| 2024-08-22 | At Loss | 2024-06-19 | At Loss |
| 2024-08-21 | At Loss | 2024-06-18 | At Loss |
| 2024-08-20 | At Loss | 2024-06-17 | At Loss |
| 2024-08-19 | At Loss | 2024-06-14 | At Loss |
| 2024-08-16 | At Loss | 2024-06-13 | At Loss |
| 2024-08-15 | At Loss | 2024-06-12 | At Loss |
| 2024-08-14 | At Loss | 2024-06-11 | At Loss |
| 2024-08-13 | At Loss | 2024-06-10 | At Loss |
| 2024-08-12 | At Loss | 2024-06-07 | At Loss |
| 2024-08-09 | At Loss | 2024-06-05 | At Loss |
| 2024-08-08 | At Loss | 2024-06-04 | At Loss |
| 2024-08-07 | At Loss | 2024-06-03 | At Loss |
| 2024-08-06 | At Loss | 2024-05-31 | At Loss |
| 2024-08-05 | At Loss | 2024-05-30 | At Loss |
| 2024-08-02 | At Loss | 2024-05-29 | At Loss |
| 2024-08-01 | At Loss | 2024-05-28 | At Loss |
| 2024-07-31 | At Loss | 2024-05-27 | At Loss |
| 2024-07-30 | At Loss | 2024-05-24 | At Loss |
| 2024-07-29 | At Loss | 2024-05-23 | At Loss |
| 2024-07-26 | At Loss | 2024-05-22 | At Loss |
| 2024-07-25 | At Loss | 2024-05-21 | At Loss |
| 2024-07-24 | At Loss | 2024-05-20 | At Loss |
| 2024-07-23 | At Loss | 2024-05-17 | At Loss |
Saniona AB (OSTO:SANION) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Saniona AB
ISIN : SE0005794617
Compare
Compare
Traded in other countries / regions
SANION.Sweden30S.Germany0RQJ.UK IPO Date
2014-04-22Description
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers